53 related articles for article (PubMed ID: 3029224)
21. Mechanisms involved in the bidirectional effects of protein kinase C activators on neutrophil responses to leukotriene B4.
O'Flaherty JT; Redman JF; Jacobson DP
J Immunol; 1990 Mar; 144(5):1909-13. PubMed ID: 2155269
[TBL] [Abstract][Full Text] [Related]
22. Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE.
O'Flaherty JT
J Cell Physiol; 1985 Feb; 122(2):229-39. PubMed ID: 2981891
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of phorbol ester-induced protein kinase activity in human neutrophils by platelet-activating factor.
Gay JC; Stitt ES
J Cell Physiol; 1988 Dec; 137(3):439-47. PubMed ID: 3192624
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil degranulation responses to combinations of arachidonate metabolites and platelet-activating factor.
O'Flaherty JT; Wykle RL; Thomas MJ; McCall CE
Res Commun Chem Pathol Pharmacol; 1984 Jan; 43(1):3-23. PubMed ID: 6322256
[TBL] [Abstract][Full Text] [Related]
25. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway.
Liles WC; Meier KE; Henderson WR
J Immunol; 1987 May; 138(10):3396-402. PubMed ID: 3033073
[TBL] [Abstract][Full Text] [Related]
26. Arachidonate metabolites, platelet-activating factor, and the mobilization of protein kinase C in human polymorphonuclear neutrophils.
O'Flaherty JT; Nishihira J
J Immunol; 1987 Mar; 138(6):1889-95. PubMed ID: 3029224
[TBL] [Abstract][Full Text] [Related]
27. Adenosine. An endogenous inhibitor of arachidonic acid release and leukotriene biosynthesis in human neutrophils.
Krump E; Borgeat P
Adv Exp Med Biol; 1999; 447():107-15. PubMed ID: 10086187
[TBL] [Abstract][Full Text] [Related]
28. [The potential role and mechanism of leukotriene and platelet-activating factor in allergic disease].
Yoshida K; Suko M
Nihon Rinsho; 1993 Mar; 51(3):631-7. PubMed ID: 8492436
[TBL] [Abstract][Full Text] [Related]
29. Bioactions of 5-hydroxyicosatetraenoate and its interaction with platelet-activating factor.
Rossi AG; O'Flaherty JT
Lipids; 1991 Dec; 26(12):1184-8. PubMed ID: 1668115
[TBL] [Abstract][Full Text] [Related]
30. Mediators of injury in neurotrauma: intracellular signal transduction and gene expression.
Bazan NG; Rodriguez de Turco EB; Allan G
J Neurotrauma; 1995 Oct; 12(5):791-814. PubMed ID: 8594208
[TBL] [Abstract][Full Text] [Related]
31. Molecular and cellular properties of human polymorphonuclear leukocyte receptors for leukotriene B4.
Goldman DW; Gifford LA; Marotti T; Koo CH; Goetzl EJ
Fed Proc; 1987 Jan; 46(1):200-3. PubMed ID: 3026857
[TBL] [Abstract][Full Text] [Related]
32. Leukotriene B4 and platelet-activating factor in human skin.
Michel L; Dubertret L
Arch Dermatol Res; 1992; 284 Suppl 1():S12-7. PubMed ID: 1337424
[TBL] [Abstract][Full Text] [Related]
33. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators.
Snyder F
Am J Physiol; 1990 Nov; 259(5 Pt 1):C697-708. PubMed ID: 2240190
[TBL] [Abstract][Full Text] [Related]
34. Autacoids and some mediators in allergic and non allergic forms.
Ghezzi E
Boll Ist Sieroter Milan; 1986; 65(3):169-92. PubMed ID: 2877678
[TBL] [Abstract][Full Text] [Related]
35. Platelet-activating factor--a powerful lipid autacoid possibly involved in microangiopathy.
Bussolino F; Biffignandi P; Arese P
Acta Haematol; 1986; 75(3):129-40. PubMed ID: 3019063
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]